MedPath

A comparative study between ropivacaine versus levobupivacaine for spinal anaesthesia

Phase 4
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2024/05/067639
Lead Sponsor
Dr Sunil chiruvella
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA 1 and 2

Age between 18 to 65 years Patients undergoing unilateral inguinal hernia

Exclusion Criteria

Coagulation disorders

Local site infection

Neurological disorders

Psychiatric disorders

Patient refusal

Hypersensitivity to drugs used in the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare onset and duration of sensory and motor blockadeTimepoint: 2 min <br/ ><br>3 min <br/ ><br>6 min <br/ ><br>10 min <br/ ><br>15 min <br/ ><br>30 min <br/ ><br>45 min <br/ ><br>60 min <br/ ><br>2 hr <br/ ><br>3 hr <br/ ><br>6 hr
Secondary Outcome Measures
NameTimeMethod
To monitor hemodynamic parameters and observe adverse effectsTimepoint: 2 m8n <br/ ><br>3 min <br/ ><br>6 min <br/ ><br>10 min <br/ ><br>15 min <br/ ><br>30 min <br/ ><br>45 min <br/ ><br>60 min <br/ ><br>2 hr <br/ ><br>3 hr <br/ ><br>6 hr
© Copyright 2025. All Rights Reserved by MedPath